BioSpace News Archive

Business

Promore Pharma: Interim Report January - March 2023

In April the results from the company’s Phase II study PHSU05 were announced. No clear differences in the efficacy on reducing the scarring were observed between ensereptide and placebo.

May 23, 2023
·
2 min read
smartbax Announces Seed Financing of €1.2 Million to Develop Next-generation Antibiotics

smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, announced the close of its seed financing round of €1.2 million from Boehringer Ingelheim Venture Fund and High-Tech Gründerfonds, bringing smartbax’s total capital raised to €1.9 million.

May 23, 2023
·
5 min read
Genetown

Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer

Larkspur Biosciences, a biotechnology company building the next precision immunotherapies to outsmart cancer, launched with $35.5 million in combined seed and Series A financing.

May 23, 2023
·
4 min read
Policy

Antengene Announces Claudin 18.2 Antibody-Drug Conjugate ATG-022 Granted Orphan Drug Designations by the U.S. FDA for the Treatment of Gastric and Pancreatic Cancers

Antengene Corporation Limited announced that ATG-022, a Claudin 18.2 antibody drug conjugate in-house discovered and developed by Antengene, has been granted two Orphan Drug Designations consecutively by the U.S. Food and Drug Administration for the treatment of gastric cancer and pancreatic cancer.

May 23, 2023
·
6 min read
Biotech Bay

GenScript Debuts GenTitan Gene Fragments Service to Expedite Gene Synthesis at Lower Cost

GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, announced the debut of its breakthrough GenTitan™ Gene Fragments Synthesis service.

May 23, 2023
·
4 min read
Genetown

ReNAgade Therapeutics Launches with over $300 Million in Series A Financing To Unlock the Limitless Potential of RNA Medicine

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines to correct disease, announced a $300 million Series A financing round led by MPM BioImpact and F2 Ventures.

May 23, 2023
·
3 min read
Largest Published Real-World Wound Imaging Study Reports MolecuLight® led to Wound Treatment Plan Changes in up to 53% Cases

MolecuLight Inc. announced the publication of their latest publication, “Lights, fluorescence, action—Influencing wound treatment plans including debridement of bacteria and biofilms"1 in the International Wound Journal.

May 23, 2023
·
6 min read
Business

Affimed Reports First Quarter 2023 Financial Results and Highlights Operational Progress

Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported financial results and provided an update on clinical and corporate progress for the first quarter of 2023.

May 23, 2023
·
15 min read
Lone Star Bio

Powered by Its Industry-Leading Comprehensive Multi-Omic Database, Caris Life Sciences to Showcase Extensive Research at ASCO 2023

Caris Life Sciences® announced that the company and collaborators within the Caris Precision Oncology Alliance™ will collectively present 42 studies across more than 30 solid tumor types at the 2023 American Society of Clinical Oncology Annual Meeting from June 2-6, 2023.

May 23, 2023
·
6 min read
Genetown

KalVista Pharmaceuticals to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day Virtual Conference

KalVista Pharmaceuticals, Inc. announced it will participate in a fireside chat at the Stifel 2023 Tailoring Genes: Genetic Medicines Day virtual conference on Tuesday, May 30, 2023 at 10:55 a.m. ET.

May 23, 2023
·
3 min read